ReviewBMC cancer2020

Clinically relevant prognostic and predictive markers for immune-checkpoint-inhibitor (ICI) therapy in non-small cell lung cancer (NSCLC).

Wolfgang M Brueckl et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.